“ra-capital-management” Archives

in
Entry Author Date Location
Freenome Tacks on $270M to Advance Blood Tests to Find Cancer Early 08/26/20 San Francisco
GentiBio Joins Cell Therapy Chase With $20M and New Treg Technology 08/05/20 Boston
Olema Adds $54M to Start Human Tests of Breast Cancer Drug Candidate 07/22/20 San Francisco
Artiva Bio Raises $78M to Broaden Access to Cancer Cell Therapies 06/26/20 San Diego
C4 Therapeutics Adds $170M to Test Protein Degraders in the Clinic 06/16/20 Boston
Viacyte Adds $27M to Move Ahead Trio of Stem Cell Diabetes Treatments 05/26/20 San Diego
Bio Roundup: Opioid Exposé, Gilead’s Gambit, Life Science IPOs & More 07/19/19 National
Austin VC Firm LiveOak Venture Partners Closes Second, $105M Fund 04/09/19 Texas
Peloton Therapeutics Raises $150M to Advance Kidney Cancer Therapy 02/20/19 Texas
Black Diamond Gets $85M for Cancer Drugs R&D and New Cambridge HQ 01/10/19 Boston
Synthorx Gets $131M in Upsized IPO for Synthetic Biology Drugs 12/07/18 San Diego
Synthorx Files for IPO to Advance Enhanced Cytokine Drugs 11/14/18 San Diego
With $90M Round, Stoke Eyes a “Spinraza For Epilepsy” And a 2019 IPO 10/23/18 Boston
Fresh Off GSK Deal, Gene Therapy Startup Orchard Bags Another $150M 08/13/18 Boston
Now Hear This: Akouos Secures $50M for Hearing Loss Gene Therapy R&D 08/07/18 Boston
Precision Bio Lands $110M as Gene-Edited Cell Therapy Nears Clinic 06/27/18 Raleigh Durham
Synthorx Raises $63M to Advance Suite of Enhanced Cytokine Drugs 04/30/18 San Diego
Prevail Gets $75M For Parkinson’s Gene Therapy, Bolstering NY Biotech 03/08/18 New York
Next Stop on Father’s Duchenne Quest: Wall Street? Solid Raises $50M 03/30/17 Boston
Google’s Venture Arm Leads $51.7M Investment in Spero Therapeutics 03/08/17 Boston
After “Hubris” and Its HCV Collapse, Can Vertex Avoid Same Mistakes? 10/18/16 Boston
Taking Aim at Alexion, Ra Pharma Heads to IPO Queue 10/03/16 Boston
Filing: Moderna Blowing Past Record $450M Round With New $600M Raise 08/29/16 Boston
Epic, Wellbe, WARF, & Arrowhead: This Week’s Wisconsin Watchlist 08/17/16 Wisconsin
Biotech Roundup: Scangos’s Exit, Zafgen’s Shakeup, Jounce, Relypsa & More 07/22/16 National
Many Biotechs Need Inside IPO Help, But Selecta Is An Extreme Case 06/22/16 Boston
RA Capital Seeds Peanut Allergy Prevention Startup With $1.7M 06/01/16 Boston
Kala Pharma Nabs $68M, Crossover Backers for Eye Drug Push 04/13/16 Boston
Waving White Flag, Celladon Merges With Rare Disease Co. Eiger Bio 11/19/15 San Diego
WaVe, Voyager Get $170M Combined in Biotech’s Latest IPO Tests 11/11/15 Boston
Page 1 of 3 next page »